Johnson & Johnson (JNJ: NYSE)
$112.69 -0.37 | -0.33%
05/31/16 - 04:03 PM ET
Portfolios with JNJ
- Portfolio NameUser Type
- ProPrem Watsa - Fairfax Financ...
- ProKen Fisher - Fisher Investm...
- ProJoel Greenblatt - Gotham Ca...
- ProJames Barrow - Barrow Hanle...
- ProDonald Yacktman - Yacktman ...
- ProBrian Rogers - T. Rowe Pric...
- ProAdage Capital
- ProAcropolis Investment Manage...
- ContributorRocket Stocks for the Week ...
Latest JNJ Headlines from TheStreet
- Jim Cramer's 'Mad Money' Recap: These Dow Stocks Doing Better Than You Believe 05.16.16 | 08:05 pm
- Jim Cramer's 'Mad Money' Recap: These Companies Win No Matter the Weather 05.10.16 | 07:05 pm
- Jim Cramer's 'Mad Money' Recap: Don't Freak Out 05.04.16 | 07:05 pm
- CAT, IBM, KO: Jim Cramer's Views 05.02.16 | 01:05 am
- Jim Cramer's 'Mad Money' Recap: Stay Positive, Stay Focused, Ignore Apple 04.26.16 | 08:04 pm
- Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan 04.15.16 | 08:04 pm
- Jim Cramer's 'Mad Money' Recap: Uncle Sam, Back Off Business! 04.07.16 | 07:04 pm
- Jim Cramer's 'Mad Money' Recap: We've Won the War Against the Dollar 03.16.16 | 07:03 pm
- Jim Cramer Says Avoid Airlines on Capacity Woes, Buy Eli Lilly 03.08.16 | 11:03 am
- Four Blue Chip Stocks to Weather a Market Storm 02.24.16 | 03:02 pm
Press Releases for JNJ
- Johnson & Johnson Announces Quarterly Dividend For Third Quarter 2015 - PR Newswire 07.20.15 | 11:07 am
- Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results - PR Newswire 06.16.15 | 04:06 pm
- CEO And Director Of Huntsman Cancer Institute Dr. Mary Beckerle Joins Johnson & Johnson Board Of Directors - PR Newswire 06.09.15 | 04:06 pm
- Johnson & Johnson Announces Acceptance Of Binding Offer From Cardinal Health To Acquire Cordis - PR Newswire 05.28.15 | 08:05 am
- Johnson & Johnson To Participate In The Goldman Sachs 36th Annual Global Healthcare Conference - PR Newswire 05.27.15 | 09:05 am
- China Diabetes Management Devices Market Growth To Be Driven By Rise In Sedentary Lifestyle And Life Expectancy And Patient Compliant Technologies Especially For Insulin Pump And CGM - PR Newswire 05.20.15 | 10:05 am
- Johnson & Johnson Pharmaceutical Segment To Continue Driving Above-Industry Growth With Plans To File More Than 10 New Products By 2019, Each With Potential To Exceed $1 Billion In Revenue - PR Newswire 05.20.15 | 07:05 am
- Johnson & Johnson Announces NYU School Of Medicine Partnership To Evaluate Compassionate Use Of Investigational Medicines - PR Newswire 05.07.15 | 12:05 am
- Johnson & Johnson To Participate In The 2015 Deutsche Bank 40th Annual Health Care Conference - PR Newswire 04.30.15 | 09:04 am
- Johnson & Johnson Announces Further Patent And Trademark Office Action Related To REMICADE® - PR Newswire 04.29.15 | 04:04 pm
Partner Headlines for JNJ
- Perrigo Company (PRGO) Ex-Dividend Date Scheduled for May 25, 2016 - NASDAQ 05.24.16 | 01:05 pm
- Johnson & Johnson initiated with a Sell at Standpoint Research - The Fly 05.20.16 | 07:05 am
- Deutsche does not expect break up at Johnson & Johnson - The Fly 05.20.16 | 06:05 am
- Johnson & Johnson (JNJ) Ex-Dividend Date Scheduled for May 20, 2016 - NASDAQ 05.19.16 | 01:05 pm
- Teva Pharmaceutical Industries Limited (TEVA) Ex-Dividend Date Scheduled for May 20, 2016 - NASDAQ 05.19.16 | 01:05 pm
- Johnson & Johnson medical services poised for growth acceleration, says Leerink - The Fly 05.19.16 | 08:05 am
- J&J CEO: Consumer brands, medical devices poised for growth - CNBC 05.18.16 | 09:05 am
- J&J's Baby Needs a Makeover as Moms Go Natural With Jessica Alba - Bloomberg 05.17.16 | 01:05 pm
- Johnson & Johnson remains a top pick, says UBS - The Fly 05.16.16 | 07:05 am
- Johnson & Johnson slips after analyst digs at device prospects - CNBC 05.13.16 | 04:05 pm